UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pycnogenol® Effects on Skin Elasticity and Hydration Coincide with Increased Gene Expressions of Collagen Type I and Hyaluronic Acid Synthase in Women

Skin pharmacology and physiology, 2012-01, Vol.25 (2), p.86-92

2012

Volltextzugriff (PDF)

Ultrasound therapy for recalcitrant diabetic foot ulcers: results of a randomized, double-blind, controlled, multicenter study

Ostomy/wound management, 2005-08, Vol.51 (8), p.24

2005

Volltextzugriff (PDF)

Dissecting nonthermal emission in the complex multiple-merger galaxy cluster Abell 2744: Radio and X-ray analysis

Astronomy and astrophysics (Berlin), 2021-10, Vol.654, p.A41

2021

Volltextzugriff (PDF)

Potential predictors in neonaticide: the impact of the circumstances of pregnancy

Archives of women's mental health, 2012-06, Vol.15 (3), p.167-174

2012

Volltextzugriff (PDF)

Long‐term follow‐up of chronic hepatitis C patients with sustained virological response to various forms of interferon‐based anti‐viral therapy

Alimentary pharmacology & therapeutics, 2006-02, Vol.23 (4), p.507-511

2006

Volltextzugriff (PDF)

Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection

Journal of hepatology, 2006-02, Vol.44 (2), p.275-282

2006

Volltextzugriff (PDF)

Tongue and Skin Hyperpigmentation During PEG-Interferon-α/Ribavirin Therapy in Dark-Skinned Non-Caucasian Patients with Chronic Hepatitis C

The American journal of gastroenterology, 2006-01, Vol.101 (1), p.197-198

2006

Volltextzugriff (PDF)

Prospective study of viral clearance and CD4 + T-cell response in acute hepatitis C primary infection and reinfection

Journal of clinical virology, 2006-05, Vol.36 (1), p.24-31

2006

Volltextzugriff (PDF)

Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection

AIDS (London), 2005-10, Vol.19 Suppl 3 (Suppl 3), p.S85-S92

2005

Volltextzugriff (PDF)

Successful Treatment of Chronic Hepatitis D with a Short Course of Peginterferon alfa-2a

The American journal of gastroenterology, 2005-07, Vol.100 (7), p.1626-1627

2005

Volltextzugriff (PDF)

Twice-weekly administration of peginterferon-α-2b improves viral kinetics in patients with chronic hepatitis C genotype 1

Journal of viral hepatitis, 2003-07, Vol.10 (4), p.271-276

2003

Volltextzugriff (PDF)

Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1

Journal of viral hepatitis, 2003-07, Vol.10 (4), p.271-276

2003

Volltextzugriff (PDF)

Sudden Hearing Loss in Patients with Chronic Hepatitis C Treated with Pegylated Interferon Ribavirin

The American journal of gastroenterology, 2004-05, Vol.99 (5), p.873-877

2004

Volltextzugriff (PDF)

798 VERY EARLY VIRAL KINETICS ON INTERFERON TREATMENT IN CHRONIC HEPATITIS C VIRUS GENOTYPE 4 INFECTION

Journal of hepatology, 2008, Vol.48, p.S298-S298

2008

Volltextzugriff (PDF)

Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis C

Thrombosis and haemostasis, 2006-02, Vol.95 (2), p.260-266

2006

Volltextzugriff (PDF)

Short‐ and long‐term effects of therapy with interferon‐α and pegylated interferon‐α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2005-01, Vol.21 (1), p.49-55

2005

Volltextzugriff (PDF)

Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV Monitor, Version 2.0, assays in HCV genotype 4 infection

Journal of viral hepatitis, 2007-11, Vol.14 (11), p.775-781

2007

Volltextzugriff (PDF)

419 Apoptosis combined with virus load on day 1 of IFN treatment as a predictive marker of response to IFN therapy of chronic hepatitis C

Journal of hepatology, 2006-04, Vol.44, p.S157-S157

2006

Volltextzugriff (PDF)

Weighted closest pairs

STACS 93, 2005, p.270-281

2005

Volltextzugriff (PDF)

Hepatitis C viral dynamics: basic concept and clinical significance

Journal of Clinical Virology, 2002-12, Vol.25 (S3), p.31-39

2002

Volltextzugriff (PDF)

Einfluss der Therapie mit pegyliertem Interferon-α auf die Thrombozytenfunktion und von Willebrand Faktor Freisetzung bei Patienten mit chronischer Hepatitis C

Zeitschrift für Gastroenterologie, 2004, Vol.42 (5)

2004

Volltextzugriff (PDF)

Very early viral kinetics on interferon treatment in chronic hepatitis C virus genotype 4 infection

Antiviral therapy, 2008-01, Vol.13 (4), p.581-589

2008

Volltextzugriff (PDF)

989 Genetic variations of interferon activation have no effect on response to antiviral therapy in chronic hepatitis C-genotype 1

Hepatology (Baltimore, Md.), 2003, Vol.38, p.632-632

2003

Volltextzugriff (PDF)

Short- and long-term effects of therapy with interferon-a and pegylated interferon-α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2005, Vol.21 (1), p.49-55

2005

Volltextzugriff (PDF)

Interferon sensitivity in chronic hepatitis C virus genotype 4 infection

Journal of hepatology, 2003-04, Vol.38, p.147-148

2003

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(24)

Publikationsform

Sprache

Englisch
(30)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Humans
(16)
Life Sciences & Biomedicine
(16)
Female
(13)
Adult
(12)
Infectious Diseases
(11)
Male
(11)
Middle Aged
(11)
Recombinant Proteins
(10)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Gastroenterology & Hepatology
(8)
Hepatitis C, Chronic - Drug Therapy
(8)
Human Viral Diseases
(8)
Interferon-Alpha - Therapeutic Use
(8)
Viral Diseases
(8)
Viral Hepatitis
(8)
Drug Therapy, Combination
(7)
Hepatitis C Virus
(7)
Polyethylene Glycols - Therapeutic Use
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pycnogenol® Effects on Skin Elasticity and Hydration Coincide with Increased Gene Expressions of Collagen Type I and Hyaluronic Acid Synthase in Women

Ultrasound therapy for recalcitrant diabetic foot ulcers: results of a randomized, double-blind, controlled, multicenter study

Dissecting nonthermal emission in the complex multiple-merger galaxy cluster Abell 2744: Radio and X-ray analysis

Potential predictors in neonaticide: the impact of the circumstances of pregnancy

Long‐term follow‐up of chronic hepatitis C patients with sustained virological response to various forms of interferon‐based anti‐viral therapy

Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection

Tongue and Skin Hyperpigmentation During PEG-Interferon-α/Ribavirin Therapy in Dark-Skinned Non-Caucasian Patients with Chronic Hepatitis C

Prospective study of viral clearance and CD4 + T-cell response in acute hepatitis C primary infection and reinfection

Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection

Successful Treatment of Chronic Hepatitis D with a Short Course of Peginterferon alfa-2a

Twice-weekly administration of peginterferon-α-2b improves viral kinetics in patients with chronic hepatitis C genotype 1

Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1

Sudden Hearing Loss in Patients with Chronic Hepatitis C Treated with Pegylated Interferon Ribavirin

798 VERY EARLY VIRAL KINETICS ON INTERFERON TREATMENT IN CHRONIC HEPATITIS C VIRUS GENOTYPE 4 INFECTION

Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis C

Short‐ and long‐term effects of therapy with interferon‐α and pegylated interferon‐α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV Monitor, Version 2.0, assays in HCV genotype 4 infection

419 Apoptosis combined with virus load on day 1 of IFN treatment as a predictive marker of response to IFN therapy of chronic hepatitis C

Weighted closest pairs

Hepatitis C viral dynamics: basic concept and clinical significance

Einfluss der Therapie mit pegyliertem Interferon-α auf die Thrombozytenfunktion und von Willebrand Faktor Freisetzung bei Patienten mit chronischer Hepatitis C

Very early viral kinetics on interferon treatment in chronic hepatitis C virus genotype 4 infection

989 Genetic variations of interferon activation have no effect on response to antiviral therapy in chronic hepatitis C-genotype 1

Short- and long-term effects of therapy with interferon-a and pegylated interferon-α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

Interferon sensitivity in chronic hepatitis C virus genotype 4 infection

Suchergebnisse filtern